Dr Tony Keating . Interesting read
The Board has appointed Chris Ntoumenopoulos as Non-executive Chair of the Company.Additionally, the Board wishes to advise of the appointment of Anthony Keating as Non-executive Director, effective immediately.
Dr Tony Keating is an experienced entrepreneur and CEO. Tony co-founded and led ResAppHealth from start-up to $180M acquisition by Pfizer.
ResApp achieved CE marking as well asFDA and TGA approvals for its digital health products and secured partnerships with multiplebiopharmaceutical and healthcare companies.
Following ResApp's acquisition by Pfizer in 2022, Tony was a Vice President at Pfizer leadingthe integration of ResApp's business in Pfizer.
Prior to co-founding ResApp, Tony was Director,Commercial Engagement at UniQuest where he led commercialisation of science-basedtechnologies which included identification, development and funding of opportunities aswell as sourcing and negotiating transactions with investors and strategic partners.
IMO
Dr Tony Keating . Interesting readThe Board has appointed Chris...
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.507M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16486 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 223020 | 1 |
View Market Depth
| Last trade - 10.16am 10/05/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable